The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zabolotskikh I.B.

Kuban State Medical University;
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitation;
Krasnodar Regional Clinical Hospital No. 2

Bautin A.E.

Almazov National Medical Research Centre

Bayalieva A.Zh.

Kazan State Medical University

Grigoryev S.V.

Kuban State Medical University

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov

Kirov M.Yu.

Northern State Medical University

Kuzovlev A.N.

Negovsky Research Institute of Intensive Care

Lebedinskii K.M.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitation;
Mechnikov North-West State Medical University

Perioperative management of patients with concomitant heart valve disease (2nd revision). Clinical guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists” (Part 2)

Authors:

Zabolotskikh I.B., Bautin A.E., Bayalieva A.Zh., Grigoryev S.V., Zamyatin M.N., Kirov M.Yu., Kuzovlev A.N., Lebedinskii K.M.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2025;(1): 8‑20

DOI: 10.17116/anaesthesiology20250118

Read: 1799 times

Download PDF (RU)
Contact the author
Table of contents

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CONCOMITANT HEART VALVE DISEASE (2ND REVISION). CLINICAL GUIDELINES OF THE ALL-RUSSIAN PUBLIC ORGANIZATION “FEDERATION OF ANESTHESIOLOGISTS AND REANIMATOLOGISTS” (PART 2)
PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CONCOMITANT HEART VALVE DISEASE (2ND REVISION). CLINICAL GUIDELINES OF THE ALL-RUSSIAN PUBLIC ORGANIZATION “FEDERATION OF ANESTHESIOLOGISTS AND REANIMATOLOGISTS” (PART 2)

To cite this article:

Zabolotskikh IB, Bautin AE, Bayalieva AZh, et al. . Perioperative management of patients with concomitant heart valve disease (2nd revision). Clinical guidelines of the All-Russian Public Organization “Federation of Anesthesiologists and Reanimatologists” (Part 2). Russian Journal of Anesthesiology and Reanimatology. 2025;(1):8‑20. (In Russ.)
https://doi.org/10.17116/anaesthesiology20250118

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Perioperative mana­gement of patients with valvular heart disease. Clinical guidelines of the All-Russian Public Orga­nization “Federation of Anesthesiologists and Reanimatologists” (2nd revi­sion, part 1). Russian Journal of Anesthesiology and Reanimatology. 2024;(6):6-22
Comparison of prognostic scales of myasthenic crisis after thymectomy in patients with myasthenia gravis. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):63-69
Consciousness, sleep, anesthesia. What are we thinking about? Analytical review. Part II. Gene­ral anesthesia: main concepts, mechanisms and neurophysiological correlates. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):92-100
Influence of menstrual phase on the effect of rocu­ronium bromide. Russian Journal of Anesthesiology and Reanimatology. 2025;(3):14-18
Imme­diate outcomes of simu­ltaneous Cox-Maze procedure in patients with isolated and multivalvular heart defe­cts via right mini-thoracotomy. Piro­gov Russian Journal of Surgery. 2024;(12-2):18-24
Current trends in orga­nizing the care for patients with acquired heart valve disease. Russian Cardiology Bulletin. 2024;(4):5-12
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80
Vaccination against pneumococcal infe­ction as a mean of redu­cing morbidity and mortality of the adult popu­lation from risk groups in the Russian Fede­ration. (Resolution of the Council of Expe­rts). Russian Journal of Preventive Medi­cine. 2025;(7):7-14
Mice and rats wound infe­ction models for testing new drugs under deve­lopment. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):9-24
Abstract:

Perioperative management of patients with concomitant heart valve disease is a serious problem considering different hemodynamic changes following valvular lesions. Considering modern data, we updated features of clinical and instrumental preoperative assessment of these patients. Guidelines on prevention of thrombosis, infectious endocarditis and intraoperative monitoring are given. Details on perioperative management of different frequent valvular diseases including preoperative management, goals of anesthesia, choice of optimal anesthesia technique and drugs are presented.

Keywords:

valvular heart disease
perioperative management
anesthesia
guidelines

Authors:

Zabolotskikh I.B.

Kuban State Medical University;
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitation;
Krasnodar Regional Clinical Hospital No. 2

Bautin A.E.

Almazov National Medical Research Centre

Bayalieva A.Zh.

Kazan State Medical University

Grigoryev S.V.

Kuban State Medical University

Zamyatin M.N.

National Medical and Surgical Center named after N.I. Pirogov

Kirov M.Yu.

Northern State Medical University

Kuzovlev A.N.

Negovsky Research Institute of Intensive Care

Lebedinskii K.M.

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitation;
Mechnikov North-West State Medical University

Received:

10.09.2024

Accepted:

19.10.2024

Close metadata

References:

  1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.  https://doi.org/10.1093/eurheartj/ehab395
  2. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van Der Meer P, Wojakowski W, Zacharowski K; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022 Oct 14;43(39):3826-3924. https://doi.org/10.1093/eurheartj/ehac270
  3. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630-634.  https://doi.org/10.1016/s0735-1097(96)00563-3
  4. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007;50(13):1205-1213. https://doi.org/10.1016/j.jacc.2007.06.024
  5. Reid CL, Anton-Culver H, Yunis C, Gardin JM. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol. 2007;99(6):830-834.  https://doi.org/10.1016/j.amjcard.2006.10.048
  6. Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30(9):962-970.  https://doi.org/10.1016/j.cjca.2014.03.022
  7. Chikwe J, Walther A, Pepper J. The Surgical Management of Mitral Valve Disease. Br J Cardiol. 2004;11(1):42-48. 
  8. Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, De Bonis M, Tribouilloy C, Evangelista A, Bogachev-Prokophiev A, Apor A, Ince H, Laroche C, Popescu BA, Piérard L, Haude M, Hindricks G, Ruschitzka F, Windecker S, Bax JJ, Maggioni A, Vahanian A; EORP VHD II Investigators. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019;140(14):1156-1169. https://doi.org/10.1161/CIRCULATIONAHA.119.041080.
  9. Tashiro T, Pislaru SV, Blustin JM, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J. 2014;35(35):2372-2381. https://doi.org/10.1093/eurheartj/ehu044
  10. Trekova NA et al. Anesteziya v serdechno-sosudistoi khirurgii. V kn. Anesteziologiya: natsional’noe rukovodstvo. Bunyatyan AA, Mizikov VM, eds. M.: GEOTAR-Media; 2011:1004. (In Russ.).
  11. Khensli FA ml., Martin DE, Grevli GP. Per s angl. pod red. A.A. Bunatyana; per. E.A. Khomenko, A.A. Nikitin, S.A. Tsiklinskii, A.N. D’yachkov. Prakticheskaya kardioanesteziologiya. 5-e izd. M.: Meditsinskoe informatsionnoe agentstvo; 2017;XX:1084. (In Russ.).
  12. Herrera A. Valvular Heart Disease. Stoelting’s Anesthesia and Co-Existing Disease. 6th ed. Edited by Hines RL, Marschall KE. Saunders; 2012.
  13. Herrera A. Valvular Heart Disease. Hines & Marschall: Stoelting’s Anesthesia and Co-Existing Disease. 5th ed. Churchill Livingstone; 2008:676. 
  14. Morgan DzhE, Mikhail MS. Klinicheskaya anesteziologiya. Izd. 4-e. M.: Binom; 2017:1216. (In Russ.).
  15. Wong CJ, Hamlin N.P. The Perioperative Medicine Consult Handbook. Springer New York, NY; 2013. ISBN: 978-1-4614-3219-7.  https://doi.org/10.1007/978-1-4614-3220-3
  16. Nussmeier NA et al. Anesteziya pri kardiokhirurgicheskikh operatsiyakh. V kn.: Anesteziya Ronal’da Millera. Pod red. R. Millera. Per. s angl. pod obshchej red. K.M. Lebedinskogo: v 4 t. SPb: Chelovek; 2015;3:972. (In Russ.).
  17. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118(15):e523-e661. https://doi.org/10.1161/CIRCULATIONAHA.108.190748
  18. Bokeria LA. Klinicheskie rekomendatsii po vedeniyu, diagnostike i lecheniyu klapannykh porokov serdtsa. M.: Izd-vo NTsSSKh im. A.N. Bakuleva RAMN; 2009. (In Russ.).
  19. Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302-2308.
  20. Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation. 1972;45(4):878-890.  https://doi.org/10.1161/01.cir.45.4.878
  21. Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 2003;41(8):1316-1324. https://doi.org/10.1016/s0735-1097(03)00129-3
  22. Kossman CE et al. The Criteria Committee of the New York Heart Association. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. Boston, MA: Little Brown; 1964:461. 
  23. Dubin AA, March HW, Cohn K, Selzer A. Longitudinal hemodynamicand clinical study of mitral stenosis. Circulation. 1971;44:381-389. 
  24. Munt B, Legget ME, Kraft CD, Miyake-Hull CY, Fujioka M, Otto CM. Physical examination in valvular aortic stenosis: correlationwith stenosis severity and prediction of clinical outcome. AmHeart J. 1999;137:298-306. 
  25. Parker E, Craige E, Hood WP Jr. The Austin Flint murmur and thea wave of the apexcardiogram in aortic regurgitation. Circulation. 1971;43:349-359. 
  26. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL, Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14:611-644. 
  27. Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F, Jr., Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18:254-275. 
  28. De Hert S, Staender S, Fritsch G, Hinkelbein J, Afshari A, Bettelli G, Bock M, Chew MS, Coburn M, De Robertis E, Drinhaus H, Feldheiser A, Geldner G, Lahner D, Macas A, Neuhaus C, Rauch S, Santos-Ampuero MA, Solca M, Tanha N, Traskaite V, Wagner G, Wappler F. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2018;35(6):407-465.  https://doi.org/10.1097/EJA.0000000000000817
  29. Goffinet C, Kersten V, Pouleur AC, et al. Comprehensive assessment of the severity and mechanism of aortic regurgitation using multidetector CT and MR. Eur Radiol. 2010;20(2):326-336.  https://doi.org/10.1007/s00330-009-1544-x
  30. Jeger RV, Probst C, Arsenic R, et al. Long-term prognostic value of the preoperative 12-lead electrocardiogram before major noncardiac surgery in coronary artery disease. Am Heart J. 2006;151(2):508-513.  https://doi.org/10.1016/j.ahj.2005.04.018
  31. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262-2270. https://doi.org/10.1161/01.cir.95.9.2262
  32. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26(13):1309-1313. https://doi.org/10.1093/eurheartj/ehi250
  33. 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.).
  34. Ostryi koronarnyj sindrom bez pod”ema segmenta ST elektokardiogrammy. Klinicheskie rekomendatsii. Rossijskoe kardiologicheskoe obshchestvo, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
  35. Ostryi infarkt miokarda s pod»emom segmenta ST elektrokardiogrammy. Klinicheskie rekomendatsii. Rossijskoe kardiologicheskoe obshchestvo, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
  36. Taniguchi T, Morimoto T, Shiomi H, et al. Elective Non-Cardiac Surgery in Patients With Severe Aortic Stenosis — Observations From the CURRENT AS Registry. Circ J. 2020;84(7):1173-1182. https://doi.org/10.1253/circj.CJ-20-0026
  37. Luis SA, Dohaei A, Chandrashekar P, et al. Impact of Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes Following Major Noncardiac Surgery. Mayo Clin Proc. 2020;95(4):727-737.  https://doi.org/10.1016/j.mayocp.2019.10.038
  38. Okuno T, Yahagi K, Horiuchi Y, et al. The role of transcatheter aortic valve replacement in the patients with severe aortic stenosis requiring major non-cardiac surgery. Cardiovasc Interv Ther. 2019;34(4):345-351.  https://doi.org/10.1007/s12928-019-00575-z
  39. Calleja AM, Dommaraju S, Gaddam R, Cha S, Khandheria BK, Chaliki HP. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 2010;105(8):1159-1163. https://doi.org/10.1016/j.amjcard.2009.12.019
  40. Tarantini G, Nai Fovino L, Tellaroli P, Fabris T, Iliceto S. Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery. Am J Cardiol. 2016;117(3): 486-488.  https://doi.org/10.1016/j.amjcard.2015.11.020
  41. Sohrabi B, Kazemi B, Mehryar A, Teimouri-Dereshki A, Toufan M, Aslanabadi N. Correlation between Pulmonary Artery Pressure Measured by Echocardiography and Right Heart Catheterization in Patients with Rheumatic Mitral Valve Stenosis (A Prospective Study). Echocardiography. 2016;33(1):7-13.  https://doi.org/10.1111/echo.13000
  42. Bajaj NS, Agarwal S, Rajamanickam A, Parashar A, Poddar KL, Griffin BP, et al. Impact of severe mitral regurgitation on postoperative outcomes after noncardiac surgery. Am J Med. 2013;126:529-535. 
  43. Authors/Task Force Members:; McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131.  https://doi.org/10.1002/ejhf.2333
  44. Zabolotskikh IB, Bautin AE, Zamyatin MN, Lebedinskii KM, Potievskaya VI, Trembach NV. Perioperative management of patients with chronic heart failure. Russian Journal of Anesthesiology and Reanimatology. 2019;3:5-24. (In Russ.). https://doi.org/10.17116/anaesthesiology20190315
  45. Shiffermiller JF, Monson BJ, Vokoun CW, et al. Prospective Randomized Evaluation of Preoperative Angiotensin-Converting Enzyme Inhibition (PREOP-ACEI). J Hosp Med. 2018;13(10):661-667.  https://doi.org/10.12788/jhm.3036
  46. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498.  https://doi.org/10.1093/eurheartj/ehaa612
  47. Bonfanti L, Annovi A, Sanchis-Gomar F, Saccenti C, Meschi T, Ticinesi A, Cervellin G. Effectiveness and safety of electrical cardioversion for acute-onset atrial fibrillation in the emergency department: a real-world 10-year single center experience. Clin Exp Emerg Med. 2019 Mar;6(1):64-69.  https://doi.org/10.15441/ceem.17.286
  48. Nadzheludochkovye takhikardii. Klinicheskie rekomendatsii RKO, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
  49. Zabolotskikh IB, Lebedinskii KM, Potievskaya VI, Bautin AE, Eremenko AA, Alekseeva YuM, Doroginin SV. Perioperative management of patients with ventricular tachycardia. Russian Journal of Anesthesiology and Reanimatology. 2020;(6):6-22. (In Russ.). https://doi.org/10.17116/anaesthesiology20200616
  50. Kheiri B, Barbarawi M, Zayed Y, Hicks M, Osman M, Rashdan L, Kyi HH, Bachuwa G, Hassan M, Stecker EC, Nazer B, Bhatt DL. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol. 2019 Nov;12(11):e007600. https://doi.org/10.1161/CIRCEP.119.007600
  51. Martinez BK, Baker WL, Konopka A, Giannelli D, Coleman CI, Kluger J, Cronin EM. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020 Jan;17(1):e206-e219. https://doi.org/10.1016/j.hrthm.2019.04.024
  52. Sapp JL,Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS. Ventricular Tachycardia Ablation versus Escalation of coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010 Jan 2;375(9708):31-40.  https://doi.org/10.1016/S0140-6736(09)61755-4.
  53. Zheludochkovye narusheniya ritma. Zheludochkovye takhikardii i vnezapnaya smert’. Klinicheskie rekomendatsii RKO, 2020. (In Russ.). Elektronnyj dokument: https://scardio.ru/rekomendacii/rekomendacii_rko
  54. Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Committee RAS, Investigators. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. Eur Heart J. 2014;35(47):3377-3385. https://doi.org/10.1093/eurheartj/ehu305
  55. Avezum A, Lopes RD, Schulte PJ, et al. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Circulation. 2015;132(8):624-632.  https://doi.org/10.1161/CIRCULATIONAHA.114.014807
  56. Ezekowitz MD, Nagarakanti R, Noack H, Brueckmann M, Litherland C, Jacobs M, Clemens A, Reilly PA, Connolly SJ, Yusuf S, Wallentin L. Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). Circulation. 2016;134:589-59 
  57. Guimaraes HP, Lopes RD, de Barros ESPGM, Liporace IL, Sampaio RO, Tarasoutchi F, Hoffmann-Filho CR, de Lemos Soares Patriota R, Leiria TLL, Lamprea D, Precoma DB, Atik FA, Silveira FS, Farias FR, Barreto DO, Almeida AP, Zilli AC, de Souza Neto JD, Cavalcante MA, Figueira F, Kojima FCS, Damiani L, Santos RHN, Valeis N, Campos VB, Saraiva JFK, Fonseca FH, Pinto IM, Magalhaes CC, Ferreira JFM, Alexander JH, Pavanello R, Cavalcanti AB, Berwanger O, RIVER Trial Investigators. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med. 2020;383:2117-2126.
  58. Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GR; Explore the Efficacy and Safety of Edoxaban in Patients after Heart Valve Repair or Bioprosthetic Valve Replacement (ENAVLE) study group. Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial. J Thorac Cardiovasc Surg. 2021. https://doi.org/10.1016/j.jtcvs.2021.01.127.
  59. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962.  https://doi.org/10.1016/S0140-6736(13)62343-0
  60. Zabolotskikh IB, Kirov MY, Afonchikov VS, Bulanov AY, Grigoryev EV, Grigoryev SV, Gritsan AI, Zamyatin MN, Kurapeev IS, Lebedinskii KM, Lomivorotov VV, Lubnin AY, Ovechkin AM, Potievskaya VI, Roitman EV, Sinkov SV, Subbotin VV, Shadrin RV, Shulutko EM. Perioperative management of patients receiving long-term antithrombotic therapy. Clinical practice recommendations of the national “Federation of Anesthesiologists and Reanimatologists”. Annals of Critical Care. 2021;(3):7-26. (In Russ.). https://doi.org/10.21320/1818-474X-2021-3-7-26
  61. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635-641. 
  62. Mok CK, Boey J, Wang R, et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation. 1985;72(5):1059-1063. https://doi.org/10.1161/01.cir.72.5.1059
  63. Christersson C, James SK, Lindhagen L, Ahlsson A, Friberg O, Jeppsson A, Stahle E. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement. Heart 2020;106:838-844. 
  64. Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). Thromb Res. 2010;126(3):e167-e174. https://doi.org/10.1016/j.thromres.2010.06.017
  65. Caldeira D, David C, Santos AT, Costa J, Pinto FJ, Ferreira JJ. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis. J Thromb Haemost. 2014;12(5):650-659.  https://doi.org/10.1111/jth.12544
  66. Spyropoulos AC, Turpie AG, Dunn AS, Kaatz S, Douketis J, Jacobson A, Petersen H, REGIMEN Investigators. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol. 2008;102:883-889 
  67. Pozhidaeva AM, Irtyuga OB, Yakubov AV, Badalyan N., Zhuravleva MS, Sefieva GG, Shadrina UM, Li OA, Pervunina TM, Zazerskaya IE, Vavilova TV, Bautin AE. Strategy of re-administering anticoagulants after delivery in patients with mechanical prosthetic heart valves. Tromboz, gemostaz i reologiya. 2023;(3):28-38. (In Russ.). https://doi.org/10.25555/THR.2023.3.1066
  68. The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3036-3037. https://doi.org/10.1093/eurheartj/ehv488
  69. Roizen MF, Fleisher LA. In: Miller RD, ed. Anesthetic implication of concurred diseases in Miller’s anesthesia. 6th ed. Elsevier; 2005.
  70. Landoni G, Fochi O, Bignami E, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth. 2009;1(4):34-43. 
  71. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321(7275):1493. https://doi.org/10.1136/bmj.321.7275.1493
  72. Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of post-operative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;1:CD010108.
  73. Frasco PE, De Bruijn N.P. Cardiac Anesthesia: Principles and Practice 2002.
  74. Zabolotskikh IB, Bautin AE, Bayalieva AZh, Grigoriev SV, Zamyatin MN, Kirov MYu, Lebedinskii KM. Perioperative management of patients with valvular heart disease. Russian Journal of Anesthesiology and Reanimatology. 2020;(4):6-31. (In Russ.). https://doi.org/10.17116/anaesthesiology20200416
  75. Mueller HS, Chatterjee K, Davis KB, et al. ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology. J Am Coll Cardiol. 1998;32(3):840-864.  https://doi.org/10.1016/s0735-1097(98)00327-1
  76. American Society of Anesthesiologists and Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology. 2010;112(5):1084-1096. https://doi.org/10.1097/ALN.0b013e3181c51e90
  77. Bautin AE, Osovskikh VV, Basova VA. Ekhokardiograficheskij monitoring. V kn. Krovoobrashchenie i anesteziya. Lebedinskii KM, ed. SPb: Chelovek; 2012:365-398. (In Russ).
  78. Weng CL, Zhao YT, Liu QH, et al. Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med. 2010;152(9):590-600.  https://doi.org/10.7326/0003-4819-152-9-201005040-00009
  79. Bermejo J, González-Mansilla A, Mombiela T, et al. Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival. J Am Heart Assoc. 2021;10(2):e019949. https://doi.org/10.1161/JAHA.120.019949
  80. Pöpping DM, Elia N., Van Aken H.K. et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg. 2014 259(6):1056-67.  https://doi.org/10.1097/SLA.0000000000000237
  81. Nishimori M, Low JHS,. Zheng H, et al. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev. 2012;7:CD005059.
  82. Lakhin RE, Dunts PV, Trembach NV, Andreenko AA, Bayalieva AZh, Gorokhovsky VS, Grigoryev EV, Gritsan AI, Gruzdev VE, Ezhevskaya AA, Ershov VI, Kitiashvili IZ, Kokhno VN, Kuzovlev AN, Kuligin AV, Levit AL, Leiderman IN, Magomedov MA, Myasnikova VV, Ovezov AM, Orlov YuP, Popugaev KA, Potievskaya VI, Savvina IA, Sitkin SI, Spasova AP, Fisher VV, Khoronenko VE, Shen NP. Analysis of the guideline “Perioperative management of patients with coronary artery disease”, “Perioperative management of patients with concomitant pathology of the heart valves” and “Perioperative management of patients with concomitant morbid obesity”: modified Delphi method. Annals of Critical Care. 2024;2:21-30. (In Russ.). https://doi.org/10.21320/1818-474X-2024-2-21-30
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.